Prot #CNDO109-001: A Phase 1/2 Study of CNDO-109-Activated Allogeneic Natural Killer Cells in Patients with High Risk Acute Myeloid Leukemia in First Complete Remission (CR1)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/10/122/10/18

Funding

  • Coronado Biosciences, Inc. (Prot #CNDO109-001)